Product Categories
| Country: | China |
|---|---|
| Tel: | 021-59167510 |
| Mobile: | 18117107507 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| AP1867 | C38H47NO11 | 195514-23-9 | Details |
| SLF TFA | C32H41F3N2O8 | 2378802-47-0 | Details |
| FKBP12 PROTAC dTAG-7 | C63H79N5O19 | 2064175-32-0 | Details |
| AP1867-3-(aminoethoxy) | C38H50N2O9 | 2127390-15-0 | Details |
| KB02-SLF | C50H65ClN4O12 | 2384184-40-9 | Details |
| Quiflapon sodium | C34H34ClN2NaO3S | 147030-01-1 | Details |
| AM103 | C36H40N3NaO4S | 1147872-22-7 | Details |
| Diflapolin | C22H17Cl2N3O2S | 724453-98-9 | Details |
| TAK-659 hydrochloride | C17H22ClFN6O | 1952251-28-3 | Details |
| MRX-2843 | C29H40N6O | 1429882-07-4 | Details |
| TG101209 | C26H35N7O2S | 936091-14-4 | Details |
| FLT3-IN-3 | C27H38N8O | 2229050-90-0 | Details |
| UNC2025 hydrochloride | C28H41ClN6O | 2070015-17-5 | Details |
| Gilteritinib | C29H44N8O3 | 1254053-43-4 | Details |
| Gilteritinib hemifumarate | C33H48N8O7 | 1254053-84-3 | Details |
| FLT3-IN-6 | C23H25N5O3 | 2377141-31-4 | Details |
| Fostamatinib Disodium | C23H27FN6NaO9P | 1025687-58-4 | Details |
| OTS447 | C27H32ClN3O2 | 1356943-67-3 | Details |
| HM43239 | C29H33ClN6 | 2294874-49-8 | Details |
| ATH686 | C25H28F3N7O2 | 853299-52-2 | Details |
| 4SC-203 | C33H38N8O4S | 895533-09-2 | Details |
| Fostamatinib | C23H26FN6O9P | 901119-35-5 | Details |
| Emavusertib | C24H25N7O5 | 1801344-14-8 | Details |
| Pacritinib | C28H32N4O3 | 937272-79-2 | Details |
| AG-09/1 | C16H14N4O4S | 356776-32-4 | Details |
| HCH6-1 | C28H27N3O4 | 1435265-06-7 | Details |
| FPR Agonist 43 | C20H21ClN4O2 | 903895-98-7 | Details |
| {Boc}-Phe-Leu-Phe-Leu-Phe | C44H59N5O8 | 66556-73-8 | Details |
| BMS-986235 | C18H17F2N3O3 | 2253947-47-4 | Details |
| GPR120 Agonist 2 | C22H25ClO4 | 1234844-11-1 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| TUG-1375 | C22H19ClN2O4S | 2247372-59-2 | Details |
| AMG7703 | C14H15ClN2OS | 1103523-24-5 | Details |
| TUG-469 | C23H23NO2 | 1236109-67-3 | Details |
| AM-4668 | C24H19F3N2O4S | 1011531-27-3 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| AM-1638 | C33H35FO4 | 1142214-62-7 | Details |
| GPR40 agonist 6 | C20H19NO4 | 1798751-25-3 | Details |
| LY2922470 | C28H29NO4S | 1423018-12-5 | Details |
| AH 7614 | C20H17NO3S | 6326-06-3 | Details |
| Fezagepras sodium | C13H19NaO2 | 1254472-97-3 | Details |
| TUG-770 | C19H14FNO2 | 1402601-82-4 | Details |
| TAK-875 | C29H32O7S | 1000413-72-8 | Details |
| FB23 | C18H14Cl2N2O3 | 2243736-35-6 | Details |
| PX20606 trans racemate | C29H22Cl3NO4 | 1268244-85-4 | Details |
| LY2562175 | C28H27Cl2N3O4 | 1103500-20-4 | Details |
| Cilofexor | C28H22Cl3N3O5 | 1418274-28-8 | Details |
| DY268 | C30H32N4O5S | 1609564-75-1 | Details |
| Vidofludimus | C20H18FNO4 | 717824-30-1 | Details |
| Vonafexor | C19H15Cl3N2O5S | 1192171-69-9 | Details |
| Tropifexor | C29H25F4N3O5S | 1383816-29-2 | Details |
| PP58 | C22H19Cl2N5O2 | 212391-58-7 | Details |
| Zoligratinib | C20H16N6O | 1265229-25-1 | Details |
| Derazantinib | C29H29FN4O | 1234356-69-4 | Details |
| Derazantinib Racemate | C29H29FN4O | 2309668-44-6 | Details |
| ASP5878 | C18H19F2N5O4 | 1453208-66-6 | Details |
| Bemarituzumab | 1952272-74-0 | Details |
| BO-264 | C18H19N5O3 | 2408648-20-2 | Details |
| Ponatinib hydrochloride | C29H28ClF3N6O | 1114544-31-8 | Details |
| KW-2449 | C20H20N4O | 1000669-72-6 | Details |
| S49076 | C22H22N4O4S | 1265965-22-7 | Details |
| TG 100572 Hydrochloride | C26H27Cl2N5O2 | 867331-64-4 | Details |
| FGFR1/DDR2 inhibitor 1 | C28H22F3N5O | 2308497-58-5 | Details |
| FIIN-3 | C34H36Cl2N8O4 | 1637735-84-2 | Details |
| MAX-40279 hemifumarate | C22H23FN6OS.1/2C4H4O4 | 2388506-43-0 | Details |
| MAX-40279 hemiadipate | C28H33FN6O5S | 2388506-44-1 | Details |
| Surfen dihydrochloride | C21H22Cl2N6O | 5424-37-3 | Details |
| SU4984 | C20H19N3O2 | 186610-89-9 | Details |
| ASN03576800 | C11H11NO6S | 957513-35-8 | Details |
| DSHS00884 | C12H12N4O2S2 | 675104-49-1 | Details |
| EBOV/MARV-IN-1 | C25H30F3N3O2 | 2479465-67-1 | Details |
| 2'-Deoxy-5'-O-DMT-2'-fluorouridine | C30H29FN2O7 | 146954-74-7 | Details |
| SAFit1 | C42H53NO11 | 1643125-32-9 | Details |
| SLF-amido-C2-COOH | C34H44N2O9 | 1092369-24-8 | Details |
| Shield-1 | C42H56N2O10 | 914805-33-7 | Details |
| AP1867-2-(carboxymethoxy) | C38 H47 N O11 | 2230613-03-1 | Details |
| FKBP12 PROTAC dTAG-13 | C57H68N4O15 | 2064175-41-1 | Details |
| PROTAC FLT-3 degrader 1 | C52H61N9O9S2 | 2230826-81-8 | Details |
| GW4064 | C28H22Cl3NO4 | 278779-30-9 | Details |
| XL335 | C25H24F2N2O3 | 629664-81-9 | Details |
| TC-G 1005 | C25H25N3O2 | 1415407-60-1 | Details |
| SBI-115 | C14H13ClN2O4S | 882366-16-7 | Details |
| Triamterene | C12H11N7 | 396-01-0 | Details |
| PEN (human) | C97H159N27O32 | 597578-70-6 | Details |
| Pipequaline | C22H24N2 | 77472-98-1 | Details |
| MRK-016 | C17H20N8O2 | 342652-67-9 | Details |
| NEO 376 | C20H24ClN3O | 496921-73-4 | Details |
| CP-409092 hydrochloride | C17H20ClN3O2 | 225240-86-8 | Details |
| TPA 023 | C20H22FN7O | 252977-51-8 | Details |
| THIP | C6H8N2O2 | 64603-91-4 | Details |
| Zuranolone | C25H35N3O2 | 1632051-40-1 | Details |
| SSD114 hydrochloride | C18H21ClF3N3O | 2319790-02-6 | Details |
| Radequinil | C18H14N4O3 | 219846-31-8 | Details |
| RO 4938581 | C13H8BrF2N5 | 883093-10-5 | Details |
| Pivagabine | C9H17NO3 | 69542-93-4 | Details |
| Broflanilide | C25H14BrF11N2O2 | 1207727-04-5 | Details |
| AZD7325 | C19H19FN4O2 | 942437-37-8 | Details |
| ONO-8590580 | C21H21FN6 | 1802661-73-9 | Details |
| Lotilaner | C20H14Cl3F6N3O3S | 1369852-71-0 | Details |
| Alogabat | C21H23N5O4 | 2230009-48-8 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 | ||||